Skip to content

IDG Technology Venture Investment IV, LLC

Follow

13F filer, CIK 1879976, Hong Kong, Hong Kong

IDG Technology Venture Investment IV, LLC reported $88,592,387 across 3 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-04-22.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-049650

Period
2024-03-31
Reported value
$88.6M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
COINreduced-196,425-$52.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0001104659-24-049650, largest first. % of portfolio is the value over $88,592,387, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 529,291 shares; 2024Q1: 332,866 shares 332,866$88.2M99.61%-196,425Timeline
SECOO HLDG LTDSECOO HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 545,055 shares; 2024Q1: 545,055 shares 545,055$224K0.25%0
AESTHETIC MED INTL HLDG GR LAESTHETIC MED INTL HLDG GR LQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 396,086 shares; 2024Q1: 396,086 shares 396,086$119K0.13%0

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-049650 base2024-04-22acceptance time not in the bulk data set